The “neuro” of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Annals of Neurology

• Publication date

  2016-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ana.24659PMID 27043043PMCID PMC5419586
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations

  2016cited by this paper
• Dexmedetomidine and hydromorphone: A novel pain management strategy for the oncology ward setting during anti‐GD2 immunotherapy for high‐risk neuroblastoma in children

  2015cited by this paper
• Expression of MYCN in Multipotent Sympathoadrenal Progenitors Induces Proliferation and Neural Differentiation, but Is Not Sufficient for Tumorigenesis

  2015cited by this paper
• Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome.

  2015influential reference
• Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation.

  2015cited by this paper
• Cerebellar and cortical abnormalities in paediatric opsoclonus‐myoclonus syndrome

  2015cited by this paper
• Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG).

  2015cited by this paper
• Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma

  2015cited by this paper
• The genetics of splicing in neuroblastoma.

  2015cited by this paper
• Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma

  2015cited by this paper
• A nationwide survey of opsoclonus-myoclonus syndrome in Japanese children.

  2015cited by this paper
• Schwann Cells: Development and Role in Nerve Repair.

  2015cited by this paper
• Premigratory and migratory neural crest cells are multipotent in vivo.

  2015cited by this paper
• Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

  2015cited by this paper
• 123I‐MIBG scintigraphy and 18F‐FDG‐PET imaging for diagnosing neuroblastoma

  2015cited by this paper
• Polo-like kinase 1 inhibition sensitizes neuroblastoma cells for vinca alkaloid-induced apoptosis

  2015cited by this paper
• Effect of Increased Immunosuppression on Developmental Outcome of Opsoclonus Myoclonus Syndrome (OMS)

  2015cited by this paper
• 124I-MIBG: a new promising positron-emitting radiopharmaceutical for the evaluation of neuroblastoma.

  2015cited by this paper
• Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: a prospective Phase II study

  2015cited by this paper
• Neuroblastoma models for insights into tumorigenesis and new therapies

  2015cited by this paper
• Down-regulation of the Lamin A/C in neuroblastoma triggers the expansion of tumor initiating cells

  2015cited by this paper
• A distinct gene expression signature characterizes human neuroblastoma cancer stem cells.

  2015cited by this paper
• Abstract 464: Methylase meets phosphatase: roles of PRMT and EYA1 in neuroblastoma

  2014cited by this paper
• Engineering anti‐GD2 monoclonal antibodies for cancer immunotherapy

  2014cited by this paper
• Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease

  2014cited by this paper
• Mechanisms of neuroblastoma regression

  2014cited by this paper
• CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders.

  2014cited by this paper
• Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells

  2014cited by this paper
• Expression of CXCR3 and its ligands CXCL9, ‐10 and ‐11 in paediatric opsoclonus–myoclonus syndrome

  2013cited by this paper
• The genetic landscape of high-risk neuroblastoma

  2013cited by this paper
• CCR4 Agonists CCL22 and CCL17 are Elevated in Pediatric OMS Sera: Rapid and Selective Down-Regulation of CCL22 by ACTH or Corticosteroids

  2013cited by this paper
• Kidins220/ARMS depletion is associated with the neural-to Schwann-like transition in a human neuroblastoma cell line model.

  2013cited by this paper
• BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy

  2013cited by this paper
• Long-term Follow-up of the “Wait and See” Approach to Localized Perinatal Adrenal Neuroblastoma

  2013cited by this paper
• Dependence receptor UNC5D mediates nerve growth factor depletion-induced neuroblastoma regression.

  2013cited by this paper
• Aiming at Neuroblastoma and Hitting Other Worthy Targets

  2013cited by this paper
• Neuroblastoma and MYCN.

  2013cited by this paper
• Role of BAFF in Opsoclonus‐Myoclonus syndrome, a bridge between cancer and autoimmunity

  2013cited by this paper
• The Dorsal Aorta Initiates a Molecular Cascade That Instructs Sympatho-Adrenal Specification

  2012cited by this paper
• Active Comparator-Controlled, Rater-Blinded Study of Corticotropin-Based Immunotherapies for Opsoclonus-Myoclonus Syndrome

  2012cited by this paper
• Ofatumumab for a rituximab‐allergic child with chronic‐relapsing paraneoplastic opsoclonus–myoclonus

  2012cited by this paper
• Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome

  2011cited by this paper
• Neuroblastoma epigenetics: From candidate gene approaches to genome-wide screenings

  2011cited by this paper
• Outcome and Prognostic Features in Opsoclonus-Myoclonus Syndrome From Infancy to Adult Life

  2011cited by this paper
• Cerebrospinal fluid oligoclonal bands in childhood opsoclonus-myoclonus.

  2011cited by this paper
• NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome.

  2010cited by this paper
• Trk Receptor Expression and Inhibition in Neuroblastomas

  2009cited by this paper
• On Trk—The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology

  2009cited by this paper
• Insights on Chronic-Relapsing Opsoclonus-Myoclonus From a Pilot Study of Mycophenolate Mofetil

  2009cited by this paper
• In neuroblastic tumours, Schwann cells do not harbour the genetic alterations of neuroblasts but may nevertheless share the same clonal origin

  2008cited by this paper
• Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy

  2008cited by this paper
• Neural crest progenitors and stem cells.

  2007cited by this paper
• Bcl-2-mediated potentiation of neocarzinostatin-induced apoptosis: requirement for caspase-3, sulfhydryl groups, and cleavable Bcl-2

  2006cited by this paper
• Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications

  2005cited by this paper
• Surface‐binding autoantibodies to cerebellar neurons in opsoclonus syndrome

  2005cited by this paper
• B- and T-cell markers in opsoclonus–myoclonus syndrome: Immunophenotyping of CSF lymphocytes

  2004cited by this paper
• Evidence of Cellular Immune Activation in Children With Opsoclonus-Myoclonus: Cerebrospinal Fluid Neopterin

  2004cited by this paper
• Neuroblastoma as a Neurobiological Disease

  2004cited by this paper
• The epigenetics of cancer etiology.

  2004cited by this paper
• Characteristics of stem cells from human neuroblastoma cell lines and in tumors.

  2004cited by this paper
• CSF B‐cell expansion in opsoclonus‐myoclonus syndrome: A biomarker of disease activity

  2004cited by this paper
• TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma.

  2004cited by this paper
• Bcl-2 mediates induction of neural differentiation

  2003cited by this paper
• Screening for autoantibodies in children with opsoclonus-myoclonus-ataxia.

  2002cited by this paper
• Role of caspase 3-dependent Bcl-2 cleavage in potentiation of apoptosis by Bcl-2.

  2002cited by this paper
• Screening of infants and mortality due to neuroblastoma.

  2002cited by this paper
• p75-nerve growth factor as an antiapoptotic complex: independence versus cooperativity in protection from enediyne chemotherapeutic agents.

  2002cited by this paper
• Neuroblastoma screening at one year of age.

  2002cited by this paper
• TrkA as a life and death receptor: receptor dose as a mediator of function.

  2002cited by this paper
• Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.

  2002cited by this paper
• Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.

  2001influential reference
• Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.

  2001influential reference
• Spontaneous regression of cancer: possible mechanisms.

  1998cited by this paper
• BIOLOGICAL ASPECTS OF NEUROBLASTOMA SCREENING

  1998cited by this paper
• Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.

  1997cited by this paper
• Targeted expression of MYCN causes neuroblastoma in transgenic mice

  1997cited by this paper
• Role of neurotrophins and their receptors in human neuroblastomas: a primary culture study.

  1997cited by this paper
• Potentiation of enediyne-induced apoptosis and differentiation by Bcl-2.

  1996cited by this paper
• Shift of the Cellular Oxidation‐Reduction Potential in Neural Cells Expressing Bcl‐2

  1996cited by this paper
• Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.

  1996cited by this paper
• Adjunctive treatment of murine neuroblastoma with 6-hydroxydopamine and Tempol.

  1996cited by this paper
• Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.

  1995cited by this paper
• Correlating telomerase activity levels with human neuroblastoma outcomes

  1995cited by this paper
• Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.

  1995cited by this paper
• Expression and function of TRK-B and BDNF in human neuroblastomas

  1994cited by this paper
• Specific association of human telomerase activity with immortal cells and cancer.

  1994cited by this paper
• Distinct cytotoxicity against neuroblastoma cells of peripheral blood and tumor-infiltrating lymphocytes from patients with neuroblastoma.

  1993cited by this paper
• Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.

  1993cited by this paper
• Targeted enhancement of the biological activity of the antineoplastic agent, neocarzinostatin. Studies in murine neuroblastoma cells.

  1992cited by this paper
• Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.

  1992cited by this paper
• The spontaneous regression of cancer. A review of cases from 1900 to 1987.

  1990cited by this paper
• The relationship of class I MHC antigen expression to stage IV-S disease and survival in neuroblastoma.

  1990cited by this paper
• Effects of chemical sympathectomy in neonatal and adult mice on C-1300 neuroblastoma tumor growth and catecholamine content.

  1987cited by this paper
• Modulatory effect of the sympathetic nervous system on neuroblastoma tumor growth.

  1978cited by this paper
• SCREENING OF INFANTS AND MORTALITY DUE TO NEUROBLASTOMA

  year unknowncited by this paper

• HLA and T-Cell Receptor Investigations in Idiopathic and Paraneoplastic Opsoclonus-Myoclonus in Children

  2026cites this paper
• Bexarotene Promotes Neuroblastoma SH-SY5Y Cell Differentiation to Mature Neurons with Decreased Proliferation

  2025cites this paper
• Silencing YTHDF2 Induces Apoptosis of Neuroblastoma Cells In a Cell Line–Dependent Manner via Regulating the Expression of DLK1

  2025cites this paper
• MicroRNA-1303 in cancer pathogenesis and therapy: clinical implications for biomarker development and targeted treatment strategies

  2025cites this paper
• Ganglioside Profiling Uncovers Distinct Patterns in High-Risk Neuroblastoma

  2025cites this paper
• Inferring and simulating a gene regulatory network for the sympathoadrenal differentiation from single-cell transcriptomics in human

  2025cites this paper
• Integrative analysis with machine learning identifies diagnostic and prognostic signatures in neuroblastoma based on differentially DNA methylated enhancers between INSS stage 4 and 4S neuroblastoma

  2024cites this paper
• Pan-cancer single cell and spatial transcriptomics analysis deciphers the molecular landscapes of senescence related cancer-associated fibroblasts and reveals its predictive value in neuroblastoma via integrated multi-omics analysis and machine learning

  2024cites this paper
• Leveraging Neural Crest-Derived Tumors to Identify NF1 Cancer Stem Cell Signatures

  2024cites this paper
• Neuroblastoma susceptibility and association of N7-methylguanosine modification gene polymorphisms: multi-center case-control study

  2024cites this paper
• Single‐cell RNA sequencing in pediatric research: Focusing on differentiation trajectories and immune microenvironment of neuroblastoma

  2024cites this paper
• Adrenal ganglioneuroblastoma with metastasis near the renal hilum in an adult female: A case report and review of the literature

  2024cites this paper
• CRISPR-Cas System Is an Effective Tool for Identifying Drug Combinations That Provide Synergistic Therapeutic Potential in Cancers

  2023cites this paper
• Research Progress on Effects of Ginsenoside Rg2 and Rh1 on Nervous System and Related Mechanisms

  2023cites this paper
• Multiscale Mechanobiology in Brain Physiology and Diseases

  2022cites this paper
• Investigation of mechanisms underlying the inhibitory effects of metformin against proliferation and growth of neuroblastoma SH-SY5Y cells.

  2022cites this paper
• The proneural transcription factor ASCL1 regulates cell proliferation and primes for differentiation in neuroblastoma

  2022cites this paper
• Elevated Expression of LGR5 and WNT Signaling Factors in Neuroblastoma Cells With Acquired Drug Resistance

  2022cites this paper
• Mechanism of effective combination radio-immunotherapy against 9464D-GD2, an immunologically cold murine neuroblastoma

  2022cites this paper
• Proteomic investigation of Cbl and Cbl-b in neuroblastoma cell differentiation highlights roles for SHP-2 and CDK16

  2021cites this paper
• Questioning How to Define the "Ultra-High-Risk" Subgroup of Neuroblastoma Patients.

  2021cites this paper
• Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma

  2021influential citation
• Increased Prevalence of Familial Autoimmune Disease in Children With Opsoclonus-Myoclonus Syndrome

  2021cites this paper
• RhoGTPase Signalling in Cancer Progression and Dissemination.

  2021cites this paper
• Neuroblastoma differentiation in vivo excludes cranial tumors.

  2021cites this paper
• Predicting amplification of MYCN using CpG methylation biomarkers in neuroblastoma.

  2021cites this paper
• Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma

  2021cites this paper
• miR-338-3p inhibits cell growth, invasion, and EMT process in neuroblastoma through targeting MMP-2

  2021cites this paper
• Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma

  2021cites this paper
• Peptide Dendrimers with Non-Symmetric Bola Structure Exert Long Term Effect on Glioblastoma and Neuroblastoma Cell Lines

  2021cites this paper
• Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin

  2021cites this paper
• Tumour‐derived substrate‐adherent cells promote neuroblastoma survival through secreted trophic factors

  2021cites this paper
• Sequence-dependent trafficking and activity of GDE2, a GPI-specific phospholipase promoting neuronal differentiation

  2020cites this paper
• GSK3 and miRNA in neural tissue: From brain development to neurodegenerative diseases.

  2020cites this paper
• Superparamagnetic Composite-Based GO/rGO for the Multimode Biomedical Applications

  2020cites this paper
• Dephosphorylation of the Proneural Transcription Factor ASCL1 Re-Engages a Latent Post-Mitotic Differentiation Program in Neuroblastoma

  2020cites this paper
• Staged resection of a bilateral thoracic and bilateral adrenal neuroblastoma

  2020cites this paper
• Preparation of CoS nanoparticles-cisplatin bio-conjugates and investigation of their effects on SH-SY5Y neuroblastoma cell line

  2020cites this paper
• Chronic Persistent Neuroblastoma, a Unique Presentation and Clinical Course in a Six-Year-Old Child: A Case Report

  2019cites this paper
• The presence of Y674/Y675 phosphorylated NTRK1 via TP53 repression of PTPN6 expression as a potential prognostic marker in neuroblastoma.

  2019influential citation
• Chromogranin A regulates neuroblastoma proliferation and phenotype

  2019cites this paper
• Current Pharmacotherapy for Neuroblastoma

  2019cites this paper
• Vincristine combination with Ca+2 channel blocker increase antitumor effects

  2019cites this paper
• Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia

  2019cites this paper
• Targeting β3-adrenergic receptor signaling inhibits neuroblastoma cell growth via suppressing the mTOR pathway.

  2019cites this paper
• Birth Defects and Cancer in Childhood-Dual Diseases of Development.

  2019cites this paper
• WNT Signaling in Neuroblastoma

  2019cites this paper
• β2-adrenergic receptor signaling promotes neuroblastoma cell proliferation by activating autophagy

  2019cites this paper
• [Opsoclonus myoclonus syndrome secondary to abdominal neuroblastoma. Presentation of a pediatric clinical case].

  2019cites this paper
• Targeted Doxorubicin-Loaded Bacterially Derived Nano-Cells for the Treatment of Neuroblastoma

  2018cites this paper
• Therapeutic plasma exchange for a case of refractory opsoclonus myoclonus ataxia syndrome

  2018cites this paper
• Elevated expression of LGR5 and WNT signalling factors in neuroblastoma cells with acquired drug resistance

  2018cites this paper
• Graphene Oxide Functional Nanohybrids with Magnetic Nanoparticles for Improved Vectorization of Doxorubicin to Neuroblastoma Cells

  2018cites this paper
• Neuroblastoma, opsoclonus-myoclonus ataxia syndrome and neonatal lupus with congenital heart block: is there an association?

  2018cites this paper
• Cell-Type Identification in the Autonomic Nervous System

  2018cites this paper
• Biology of Cancer; From Cellular Cancerogenesis to Supracellular Evolution of Malignant Phenotype

  2018cites this paper
• Methylation of DNA and chromatin as a mechanism of oncogenesis and therapeutic target in neuroblastoma

  2018cites this paper
• The protective autophagy activated by GANT-61 in MYCN amplified neuroblastoma cells is mediated by PERK

  2018cites this paper
• Comparative gene expression profiling of human metallothionein-3 up-regulation in neuroblastoma cells and its impact on susceptibility to cisplatin

  2017cites this paper
• A Life at the Interface: The 2017 Hower Award Lecture.

  2017cites this paper
• Germline and Somatic ALK Alterations in Neuroblastoma Patients

  2017cites this paper
• Using Chemistry to Target Neuroblastoma.

  2017cites this paper
• Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling

  2016cites this paper
• The origins and progression of CNS autoimmunity

  2016cites this paper
• Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells

  2016cites this paper
• miR-1303 promotes the proliferation of neuroblastoma cell SH-SY5Y by targeting GSK3β and SFRP1.

  2016cites this paper